Abstract:Cell cycle checkpoint function is crucial for the prevention of carcinogenesis in mammalian cells. To test the hypothesis that common sequence variants of genes in the cell cycle control pathway may affect lung cancer predisposition, we explored the associations of 11 polymorphisms in seven cell cycle control genes with lung cancer risk. We conducted a case-control study in Caucasians that included 1,518 lung cancer patients and 1,518 controls. Our results showed that when individuals with at least one variant allele were compared to homozygous wild-type carriers, a significantly increased lung cancer risk was identified for polymorphisms in p53 intron 6 (rs1625895) (odds ratio [OR] = 1.29, 95% confidence interval [CI] 1.08-1.55) and in p27 5’ untranslated region (rs34330) (OR = 1.27, 95% CI 1.01-1.60). Compared with the homozygous wild-types, the homozygous variant F31I genotype (TT) of the STK15 gene was associated with a significantly reduced risk for lung cancer (OR=0.58, 95% CI = 0.37-0.90). The AA genotype of CCND1 G870A was associated with a significantly increased risk (OR = 1.26, 95% CI 1.03-1.53) when compared with genotypes containing at least one wild-type allele. In an attempt to assess the combined influence of all the investigated polymorphisms on lung carcinogenesis, we found that compared to the reference group with one variant allele, individuals with two (OR = 1.53, 95% CI 0.97-2.41) and three or more (OR = 1.59, 95% CI 1.07-2.34) variant alleles exhibited increasing risk of lung cancer with a gene dosage effect (P for trend = 0.041). This pattern was more evident in ever smokers (P for trend = 0.037), heavy smokers (P for trend = 0.020), and older subjects (P for trend = 0.011). Higher order gene-gene interactions were evaluated using the classification and regression tree (CART) analysis, which indicated that STK15 F31I and p53 intron 6 polymorphism might be associated with lung carcinogenesis in never/light-smokers and heavy smokers, respectively. This is the first study using a polygenic strategy to elucidate the influences of a panel of cell cycle genetic polymorphisms on lung cancer risk. Our results suggest that cell cycle gene polymorphisms and smoking may function collectively to modulate the risk of lung cancer.

Polymorphisms of STK15 (Aurora-A) gene and lung cancer risk in Caucasians.

Glutathione S-transferase P1 gene Ile105Val polymorphism might be associated with lung cancer risk in the Chinese Han population.

RETRACTED ARTICLE: Glutathione S -transferase P1 gene Ile105Val polymorphism might be associated with lung cancer risk in the Chinese Han population

Nucleotide Excision Repair Gene ERCC1 19007T>C Polymorphism Contributes to Lung Cancer Susceptibility: A Meta-Analysis

GSTP1 Ala114Val Polymorphism and Colorectal Cancer Risk: a Meta-Analysis

STK15 Rs2273535 Polymorphism and Cancer Risk: a Meta-Analysis of 74,896 Subjects.

Study on the association between STK15 Phe31Ile polymorphisms and esophageal squamous cell carcinoma]

STK15 F31I Polymorphism is Associated with Breast Cancer Risk: a Meta-Analysis Involving 25,014 Subjects

Association of Aurora-A (stk15) Kinase Polymorphisms with Clinical Outcome of Esophageal Cancer Treated with Preoperative Chemoradiation

STK15 F31I polymorphism is associated with increased uterine cancer risk: A pilot study

Association between missense mutations of CYP2A13 gene and lung cancer susceptibility

Stk15 F31i Polymorphisms and Uterine Cancer Risk: A Case-Control Analysis

IL-8 –251A/T Polymorphism is Associated with Decreased Cancer Risk among Population-Based Studies: Evidence from a Meta-Analysis

GSTP1 Ile105Val polymorphism is associated with lung cancer risk among Asian population and smokers: an updated meta-analysis

ERCC2/XPD Lys751Gln and Asp312Asn Gene Polymorphism and Lung Cancer Risk: A Meta-Analysis Involving 22 Case–Control Studies

Novel Genetic Variants in the Chromosome 5p15.33 Region Associate with Lung Cancer Risk

Associations Between Polymorphisms of the XPC Gene and Lung Cancer Susceptibility: a Meta-Analysis.

Different effects of the three polymorphisms on 15q25.1 onlung cancer risk: Evidence from published literatures.

C8-04: Genetic Polymorphisms in Cell Cycle Control Pathways and Lung Cancer Risk

Potentially Functional Polymorphisms of EXO1 and Risk of Lung Cancer in a Chinese Population: A Case-Control Analysis

Influence of Common Genetic Variation on Lung Cancer Risk: Meta-Analysis of 14 900 Cases and 29 485 Controls